SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is seeing heightened volatility as traders react to a resurgence in hostilities between the U.S. and Iran, which has sparked a sharp rebound in crude prices. The community is heavily focused on the disconnect between headline-driven diplomatic news and the underlying physical supply constraints, with many actively debating whether this represents a sustainable bull trend or yet another cycle of market manipulation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp is trending as investors weigh speculative enthusiasm for its Tanbreez project's potential role in Western critical mineral supply chains against frustration over persistent stock price volatility and delayed operational catalysts. Community sentiment is deeply divided between long-term bulls highlighting strategic importance and bears questioning the company's communication, management execution, and the timeline for project milestones.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol-Myers Squibb is seeing increased investor attention as the company aggressively pivots its portfolio toward next-generation oncology and neuroscience assets like Cobenfy to offset looming patent cliffs. Community discussion is heavily focused on the company's recent strategic partnerships in AI-driven drug discovery and its active pursuit of pipeline-strengthening acquisitions, fueling speculation about potential future M&A activity.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as the community debates the company's long-term commercialization strategy, with heated discussions centered on the recent reduction in milestone payments from PowerCo and the temporary modified work arrangement for the CTO. Investors remain sharply divided between those optimistic about the technical potential of solid-state batteries in high-growth sectors like defense and data centers, and those expressing frustration over the lack of public demos and consistent downward pressure on the stock price.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is currently fueling intense community debate as investors speculate on the potential passage of the Crypto Clarity Act and its impact on the company's Ethereum treasury strategy. While some are aggressively accumulating shares amidst reports of institutional share buybacks, others are vocal in their skepticism, highlighting volatility and ongoing concerns regarding the stock's correlation to crypto market fluctuations.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to heightened investor anticipation surrounding upcoming earnings and the potential for a strategic acquisition as its Briumvi franchise continues to capture market share. Community members are actively debating the company's valuation, clinical pipeline expansion into new indications, and the significance of the CEO's continued ownership stake as they monitor for a potential buyout.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heightened activity as the community debates the company's aggressive capital management strategy, specifically surrounding its authorization to sell Bitcoin to support dividend obligations and share buybacks. Sentiment remains sharply divided, with bulls pointing toward the potential for institutional adoption and crypto market recovery, while bears express deep skepticism over dilution risks and the sustainability of the company's financial model.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is facing a pivotal binary event as its FDA advisory committee meeting and impending PDUFA decision approach, fueling intense debate between retail traders expecting a potential short squeeze and skeptics predicting a third rejection due to previously cited scientific deficiencies. Community sentiment is deeply divided, with many actively monitoring the FDA briefing documents for clues on efficacy and safety, while others focus on the stock's high short interest and the risk of significant shareholder dilution if the drug is approved.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is facing heightened volatility and intense community debate as market participants react to the temporary shelving of the Clarity Act and ongoing skepticism regarding its institutional adoption. Investors remain sharply divided, with bulls pointing to the potential for future regulatory breakthroughs and long-term utility, while bears emphasize technical weakness and historical disappointment.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are trading higher on hopes of a potential peace deal with Iran, with traders debating whether this is a genuine breakthrough or another example of recurring geopolitical volatility. The community remains deeply divided, balancing enthusiasm over the potential for an 'everything rally' against persistent skepticism regarding the credibility of these recurring headlines and the underlying stability of global indices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
